Trial Information

Summary: A Pilot Open Study of the Safety and Effectiveness of Lamotrigine for the Treatment of Mania in Youth ages 6-17 with Bipolar I, Bipolar II, and Bipolar Spectrum Disorders

Children between the ages of 6-17 years old who have, or display symptoms of bipolar disorder (explosiveness, mood swings, irritability, or violent behavior) are invited to participate in a 12-week research study to determine the effectiveness and safety of a medication called Lamictal (lamotrigine) in the treatment of children with bipolar disorder. After undergoing a comprehensive evaluation by medical doctors with a specialty in this area, children who are found eligible to participate in this research study will be treated with Lamictal and will have weekly visits for 12 weeks in an effort to closely monitor each child’s response to the medication. Eligible participants will receive study-related evaluations and weekly study visits with our study doctors at no cost.


Eligibility Criteria:
Children ages 6-17 with Bipolar disorder

If you would like to learn more about participating in this study, please send an e-mail message using the form below.